ReCerise Therapeutics is dedicated to advancing antibody-based therapies and companion diagnostics
focused on disease-driving microenvironments at the intersection of immunity and oncology.
“ReCerise” combines “Re,” meaning to restore and renew, with “Cerise,” a symbol of vitality and life,
reflecting our philosophy of restoring the body’s core biology compromised by disease.
ReCerise Therapeutics takes a unified approach that spans target discovery, therapeutics, and diagnostics,
developing therapies that deliver the right treatment to the right patient at the right time
across cancer and other difficult-to-treat diseases.